產品詳情
簡單介紹：
Anti-C5抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C5抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-C5
Cat. Number:
Anti-C5抗體KL-15197R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The complement component proteins: C2, C3, C4 and C5 are potent anaphyl-atoxins that are released during complement activation. Binding of these proteins to their respective G protein-coupled receptors, C3aR, Anti-C5抗體C1R and C5aR, induces proinflammatory events, such as cellular degranulation, smooth muscle contraction, arachidonic acid metabolism, cytokine release, leukocyte activation and cellular chemotaxis. Activation of the complement system leads to the formation of C5b-9 terminal complex, and while C5b-9 can promote cell lysis, the sublytic assembly of C5b-9 on plasma membranes causes an opposite result and induces cell cycle activation and survival. C5b-9 can rescue oligodendrocytes from FAS-mediated apoptosis by regulating caspase-8 processing via PI 3-K signaling. C5b-9 may play a pro-inflammatory role in the acute phase of multiple sclerosis, but may also be neuroprotective during the chronic phase of the disease. Complement C5 precursor contains C5a anaphylatoxin. C3a and C5a secretion correlates with pathophysiological phenotypes such as asthma and bacterial meningitis.
Also known as:
Anaphylatoxin C5a analog;Anti-C5抗體 C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; C5; C5a; CO5_HUMAN; Complement C5 alpha'' chain; Complement C5; Complement component C5; CPAMD4.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C5 .
●
Predicted Molecular Weight: 104/112kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-C5抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-C5抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-C5抗體must be determined by the end user.
kl755Mu01 干擾素調節因子4(IRF4)多克隆抗體 Polyclonal Antibody to Interferon Regulatory Factor 4 (IRF4)
kl761Ra01 抑瘤素M受體(OSMR)多克隆抗體 Polyclonal Antibody to Oncostatin M Receptor (OSMR)
kl113Hu01 生長分化因子11(GDF11)多克隆抗體 Polyclonal Antibody to Growth Differentiation Factor 11 (GDF11)
kl249Hu01 核因子κB抑制因子ζ(IκBζ)多克隆抗體 Polyclonal Antibody to Inhibitory Subunit Of NF Kappa B Zeta (IkBz)
kl249Mu01 核因子κB抑制因子ζ(IκBζ)多克隆抗體 Polyclonal Antibody to Inhibitory Subunit Of NF Kappa B Zeta (IkBz)
kl265Hu01 精神分裂癥破壞蛋白1(DISC1)多克隆抗體 Polyclonal Antibody to Disrupted In Schizophrenia 1 (DISC1)
kl265Ra01 精神分裂癥破壞蛋白1(DISC1)多克隆抗體 Polyclonal Antibody to Disrupted In Schizophrenia 1 (DISC1)
kl551Mu01 Janus激酶1(JAK1)多克隆抗體 Polyclonal Antibody to Janus Kinase 1 (JAK1)
kl680Hu01 Nicastrin蛋白(NCSTN)多克隆抗體 Polyclonal Antibody to Nicastrin (NCSTN)
kl355Hu01 AMP激活蛋白激酶γ1(PRKAγ1)多克隆抗體 Polyclonal Antibody to Protein Kinase, AMP Activated Gamma 1 (PRKAg1)
kl356Mu01 AMP激活蛋白激酶γ2(PRKAγ2)多克隆抗體 Polyclonal Antibody to Protein Kinase, AMP Activated Gamma 2 (PRKAg2)
kl577Mu01 血清/糖皮質**調節激酶3(SGK3)多克隆抗體 Polyclonal Antibody to Serum/Glucocorticoid Regulated Kinase 3 (SGK3)
kl639Mu01 受體相互作用絲氨酸蘇氨酸激酶3(RIPK3)多克隆抗體 Polyclonal Antibody to Receptor Interacting Serine Threonine Kinase 3 (RIPK3)
kl848Hu01 二酰甘油激酶ε(DGKε)多克隆抗體 Polyclonal Antibody to Diacylglycerol Kinase Epsilon (DGKe)
kl849Hu01 二酰甘油激酶γ(DGKγ)多克隆抗體 Polyclonal Antibody to Diacylglycerol Kinase Gamma (DGKg)
kl849Ra01 二酰甘油激酶γ(DGKγ)多克隆抗體 Polyclonal Antibody to Diacylglycerol Kinase Gamma (DGKg)
kl854Hu01 二酰甘油激酶ζ(DGKζ)多克隆抗體 Polyclonal Antibody to Diacylglycerol Kinase Zeta (DGKz)
kl898Hu01 連環蛋白β相互作用蛋白1(CTNNβIP1)多克隆抗體 Polyclonal Antibody to Catenin Beta Interacting Protein 1 (CTNNbIP1)
kl373Mu01 停靠蛋白3(DOK3)多克隆抗體 Polyclonal Antibody to Docking Protein 3 (DOK3)
